Title: Aarkstore - Ulcerative Colitis - Pipeline Review, H2 2014
1Ulcerative Colitis - Pipeline Review, H2 2014
Pharmaceutical and Healthcare Market Research
Report
2Summary
- Ulcerative Colitis - Pipeline Review, H2 2014,
provides an overview of the Ulcerative Colitiss
therapeutic pipeline. - This report provides comprehensive information
on the therapeutic development for Ulcerative
Colitis, complete with comparative analysis at
various stages, therapeutics assessment by drug
target, mechanism of action (MoA), route of
administration (RoA) and molecule type, along
with latest updates, and featured news and press
releases. It also reviews key players involved in
the therapeutic development for Ulcerative
Colitis and special features on late-stage and
discontinued projects. - Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team.
3Scope
- The report provides a snapshot of the global
therapeutic landscape of Ulcerative ColitisThe
report reviews key pipeline products under drug
profile section which includes, product
description, MoA and RD brief, licensing and
collaboration details other developmental
activitiesThe report reviews key players
involved in the therapeutics development for
Ulcerative Colitis and enlists all their major
and minor projectsThe report summarizes all the
dormant and discontinued pipeline projectsA
review of the Ulcerative Colitis products under
development by companies and universities/research
institutes based on information derived from
company and industry-specific sourcesPipeline
products coverage based on various stages of
development ranging from pre-registration till
discovery and undisclosed stages
Browse full report or Sample Request
_at_ http//www.aarkstore.com/pharmaceuticals-healthc
are/60599/type-2-diabetes-pipeline-review-h2-2014
4Reasons to buy
- Provides strategically significant competitor
information, analysis, and insights to formulate
effective RD development strategiesIdentify
emerging players with potentially strong product
portfolio and create effective counter-strategies
to gain competitive advantageDevelop strategic
initiatives by understanding the focus areas of
leading companiesIdentify and understand
important and diverse types of therapeutics under
development for Ulcerative ColitisPlan mergers
and acquisitions effectively by identifying key
players of the most promising pipelineDevise
corrective measures for pipeline projects by
understanding Ulcerative Colitis pipeline depth
and focus of Indication therapeuticsDevelop and
design in-licensing and out-licensing strategies
by identifying prospective partners with the most
attractive projects to enhance and expand
business potential and ScopeModify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline
5Table of Content
- IntroductionGlobal Markets Direct Report
CoverageUlcerative Colitis OverviewTherapeutics
DevelopmentPipeline Products for Ulcerative
Colitis - OverviewPipeline Products for
Ulcerative Colitis - Comparative
AnalysisUlcerative Colitis - Therapeutics under
Development by CompaniesUlcerative Colitis -
Therapeutics under Investigation by
Universities/InstitutesUlcerative Colitis -
Pipeline Products GlanceLate Stage
ProductsClinical Stage ProductsEarly Stage
ProductsUnknown Stage ProductsUlcerative
Colitis - Products under Development by
CompaniesUlcerative Colitis - Products under
Investigation by Universities/InstitutesUlcerativ
e Colitis - Companies Involved in Therapeutics
DevelopmentAjinomoto Pharmaceuticals Co., Ltd.
6List of Tables
- Number of Products under Development for
Ulcerative Colitis, H2 2014Number of Products
under Development for Ulcerative Colitis -
Comparative Analysis, H2 2014Number of Products
under Development by Companies, H2 2014Number of
Products under Development by Companies, H2 2014
(Contd..1)Number of Products under Development
by Companies, H2 2014 (Contd..2)Number of
Products under Development by Companies, H2 2014
(Contd..3)Number of Products under Development
by Companies, H2 2014 (Contd..4)Number of
Products under Investigation by
Universities/Institutes, H2 2014Comparative
Analysis by Late Stage Development, H2
2014Comparative Analysis by Clinical Stage
Development, H2 2014Comparative Analysis by
Early Stage Development, H2 2014Comparative
Analysis by Unknown Stage Development, H2
2014Products under Development by Companies, H2
2014Products under Development by Companies, H2
2014 (Contd..1)Products under Development by
Companies, H2 2014 (Contd..2)Products under
Development by Companies, H2 2014 (Contd..3)
7List of Figures
- Number of Products under Development for
Ulcerative Colitis, H2 2014Number of Products
under Development for Ulcerative Colitis -
Comparative Analysis, H2 2014Number of Products
under Development by Companies, H2 2014Number of
Products under Investigation by
Universities/Institutes, H2 2014Comparative
Analysis by Late Stage Development, H2
2014Comparative Analysis by Clinical Stage
Development, H2 2014Comparative Analysis by
Early Stage Products, H2 2014Comparative
Analysis by Unknown Stage Development, H2
2014Assessment by Monotherapy Products, H2
2014Assessment by Combination Products, H2
2014Number of Products by Top 10 Targets, H2
2014Number of Products by Stage and Top 10
Targets, H2 2014Number of Products by Top 10
Mechanism of Actions, H2 2014
8Related Reports
- Sinusitis-Pipeline Insights, 2015
- Oligodendroglioma-Pipeline Insights, 2015
- Familial Hypercholesterolemia (Type II
Hyperlipoproteinemia)-Pipeline Insights, 2015 - Fatty Liver Disease-Pipeline Insights, 2015
- Skin And Skin Structure Infections by
S.Pneumoniae-Pipeline Insights, 2015 - Opioid-Induced Constipation (OIC)-Pipeline
Insights, 2015 - Female Infertility-Pipeline Insights, 2015
- Optic Neuritis-Pipeline Insights, 2015
9Follow Us
https//www.facebook.com/aarkstoredotcom
https//twitter.com/aarkstore
https//plus.google.com/Aarkstoredotcom/posts
https//www.linkedin.com/company/aarkstore-enterpr
ise
10Contact Us
Office Address Office No. - 809, 8th
Floor,B-Wing, Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Mail us at
contact_at_aarkstore.com 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953